A Beta Strain-Based Spike Glycoprotein Vaccine Candidate Induces Broad Neutralization and Protection against SARS-CoV-2 Variants of Concern
Lei Cao(Chinese Academy of Sciences), Wenbo Xu(Shenyang Institute of Automation), Baicheng Xia(Chinese Academy of Medical Sciences & Peking Union Medical College), Dan Wu(Shanghai Children's Medical Center), Zhanjun Hou, Jinyuan Guo(National Institute for Viral Disease Control and Prevention), Tianjiao Ji(National Health and Family Planning Commission), Xiaolei Li(National Institute for Viral Disease Control and Prevention), Yanan Zhang(Dalian Medical University), Hai Li(Ningbo University), Yang Song(National Institute for Viral Disease Control and Prevention), Yan Zhang(Memorial Sloan Kettering Cancer Center), Weijia Zhao, Zhihui Chen(Chinese Academy of Sciences), Qian Yang(National Institute for Viral Disease Control and Prevention), Dongyan Wang(Heilongjiang University of Chinese Medicine), Kang Xiao(National Institute for Viral Disease Control and Prevention), Shuangli Zhu(Chinese Center For Disease Control and Prevention), Hu Ren(National Institute for Viral Disease Control and Prevention), Dongmei Yan(Chinese Center For Disease Control and Prevention), Yangzi Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 3
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
The maternal microbiota drives early postnatal innate immune development
|Science|2016|1.2k